CVE:SQD SQI Diagnostics Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SQI Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.24 -0.01 (-4.00 %) (As of 09/23/2020 09:30 AM ET) Add Compare Share Today's RangeC$0.24Now: C$0.24▼C$0.2450-Day RangeC$0.15MA: C$0.22▼C$0.2852-Week RangeC$0.05Now: C$0.24▼C$0.29Volume27,600 shsAverage Volume255,456 shsMarket CapitalizationC$73.39 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsEarningsInsider TradesHeadlinesSocial Media SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite benchtop diagnostic platform, a fully automated bench top microarray processing and analytical system; and sqid-X, a semi-automated bench-top platform. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. SQI Diagnostics Inc. has a co-develop and licensing agreement with McMaster University Department of Engineering to develop chip technology for use in multi-array disease testing; and research and development agreements with University Health Network to create and license rapid multiplexed protein assays, as well as a point-of-care diagnostic device to enable transplant surgeons assess the suitability of lungs and other organs for transplantation. The company was founded in 1999 and is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for SQI Diagnostics. Previous Next 2.7 Community Rank Outperform VotesSQI Diagnostics has received 81 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSQI Diagnostics has received 69 “underperform” votes. (Add your “underperform” vote.)Community SentimentSQI Diagnostics has received 54.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about SQI Diagnostics and other stocks. Vote “Outperform” if you believe SQD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SQD will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSQI Diagnostics does not currently pay a dividend.Dividend GrowthSQI Diagnostics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SQI Diagnostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$7,198.00 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of SQI Diagnostics is -6.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SQI Diagnostics is -6.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSQI Diagnostics has a P/B Ratio of 20.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolCVE:SQD Previous Symbol CUSIPN/A CIKN/A Websqidiagnostics.com Phone+1-416-6749500Debt Debt-to-Equity Ratio142.70 Current Ratio3.81 Quick Ratio3.43Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$1.41 million Price / Sales51.98 Cash FlowC$0.01 per share Price / Cash Flow18.93 Book ValueC$0.01 per share Price / Book20.00Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees42 Outstanding Shares305,797,000Market CapC$73.39 million Next Earnings Date12/9/2020 (Estimated) OptionableNot Optionable C$0.24 -0.01 (-4.00 %) (As of 09/23/2020 09:30 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive SQD News and Ratings via Email Sign-up to receive the latest news and ratings for SQD and its competitors with MarketBeat's FREE daily newsletter. SQI Diagnostics (CVE:SQD) Frequently Asked Questions How has SQI Diagnostics' stock price been impacted by COVID-19 (Coronavirus)? SQI Diagnostics' stock was trading at C$0.08 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SQD stock has increased by 220.0% and is now trading at C$0.24. View which stocks have been most impacted by COVID-19. When is SQI Diagnostics' next earnings date? SQI Diagnostics is scheduled to release its next quarterly earnings announcement on Wednesday, December 9th 2020. View our earnings forecast for SQI Diagnostics. How were SQI Diagnostics' earnings last quarter? SQI Diagnostics Inc. (CVE:SQD) announced its quarterly earnings results on Thursday, August, 27th. The company reported ($0.01) earnings per share for the quarter. The business earned $0.30 million during the quarter. View SQI Diagnostics' earnings history. Who are some of SQI Diagnostics' key competitors? Some companies that are related to SQI Diagnostics include Exagen (XGN), Yourgene Health (YGEN), Palatin Technologies (PTN), Senseonics (SENS), Oncimmune (ONC), Lexagene (LXG), Genedrive (GDR), Sernova (SVA), GeneNews (GEN), Cambridge Cognition (COG), LED Medical Diagnostics (LMD), Deepmatter Group (DMTR), VentriPoint Diagnostics (VPT), Imaging Dynamics (IDL) and 3D Signatures (DXD). View all competitors. What other stocks do shareholders of SQI Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other SQI Diagnostics investors own include Cigna (CI), Global Payments (GPN), AlarmCom (ALRM), Brookfield Asset Management (BAM.A), Baxter International (BAX), Becton Dickinson and (BDX), Charter Communications (CHTR), Costco Wholesale (COST), Canadian Tire (CTC.A) and CytRx (CYTR). Who are SQI Diagnostics' key executives? SQI Diagnostics' management team includes the following people: Mr. Andrew Morris, CEO, Pres & Director (Age 53)Ms. Patricia Lie CPA, CA, VP of Fin. & Admin.Dr. Eric Brouwer, Chief Scientific OfficerDr. Peter Lea Ph.D., Founder (Age 74)Mr. Russell Peloquin, VP of Global Commercial Operations What is SQI Diagnostics' stock symbol? SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD." How do I buy shares of SQI Diagnostics? Shares of SQD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is SQI Diagnostics' stock price today? One share of SQD stock can currently be purchased for approximately C$0.24. How big of a company is SQI Diagnostics? SQI Diagnostics has a market capitalization of C$73.39 million and generates C$1.41 million in revenue each year. SQI Diagnostics employs 42 workers across the globe. What is SQI Diagnostics' official website? The official website for SQI Diagnostics is sqidiagnostics.com. How can I contact SQI Diagnostics? SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The company can be reached via phone at +1-416-6749500. This page was last updated on 9/23/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
